Halloween was almost an after thought this year. The haunted doll house didn’t even make it out of the attic (which might have something to do with the fact that I am yet on crutches) and the two pumpkins that David and Peter carved were purchased just today. As we live at the end of a dead-end, on a road that is almost void of children, only one family comes to our door in costume. Peter did go trick or treating, but he is tagging along with a friend who has younger siblings and they’ve gone to a more suburban neighborhood.
In public school, Halloween has been sanitized to the point of near extinction, but at his small private school yesterday, it was alive and well. All the students in kindergarden through eighth grade marched in a parade for the high schoolers and any parents that wanted to come, and then the afternoon was devoted to merry making. Peter fashioned his own mask this year: a skeleton face with a removable eyeball.
Posts by date
Posts by title
Join 4,390 other subscribers
- ABC World News advanced lung cancer Alimta ALK+ ALK+ lung cancer ALK + lung cancer ALK inhibitors ALK mutation Alk mutations ALK positive lung cancer Attitude attitude and cancer binimetinib Camp Kesem Cancer and our children carboplatin Carboplatin and Alimta CDMRP ceritinib chemotherapy clinical trials clinical trials lung cancer Cobra coronavirus COVID-19 Crizotinib CT scans Death and dying depression and cancer Diane Legg Dr. Alice Shaw DS-1062a Dying G1202R ICRF LDK 378 LDK378 living with lung cancer living with stage IV lung cancer living with terminal lung cancer Lorbrena lorlatinib lorlatinib and binimetinib lung cancer lung cancer advocacy Marfa Marfa Texas medical research Mortality mucositis NSCLC pandemic pemetrexed PF-02341066 PF-06463922 Pfizer phase I clinical trials positive attitude and cancer progression progression lung cancer Sarah Broom SHP2 and lorlatinib side effects of cancer treatment Stage IV cancer stage IV lung cancer targeted therapies terminal cancer terminal illness terminal illness and depression terminal lung cancer TNO155 plus lorlatinib TPX-0131 triage WageWorks Xalkori
Posts by subject